Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

806 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature.
Seto Y, Kittaka N, Taniguchi A, Kanaoka H, Nakajima S, Oyama Y, Kusama H, Watanabe N, Matsui S, Nishio M, Fujisawa F, Takano K, Arita H, Nakayama T. Seto Y, et al. Among authors: oyama y. Surg Case Rep. 2022 Aug 12;8(1):155. doi: 10.1186/s40792-022-01499-2. Surg Case Rep. 2022. PMID: 35960391 Free PMC article.
Predictive factors for response to neoadjuvant chemotherapy: inflammatory and immune markers in triple-negative breast cancer.
Kusama H, Kittaka N, Soma A, Taniguchi A, Kanaoka H, Nakajima S, Oyama Y, Seto Y, Okuno J, Watanabe N, Matsui S, Nishio M, Fujisawa F, Honma K, Tamaki Y, Nakayama T. Kusama H, et al. Among authors: oyama y. Breast Cancer. 2023 Nov;30(6):1085-1093. doi: 10.1007/s12282-023-01504-y. Epub 2023 Oct 2. Breast Cancer. 2023. PMID: 37782377
Long-Term Survival Outcomes and Risk Factors for Axillary and Locoregional Recurrence in Japanese Patients with Sentinel Node-Positive Breast Cancer Treated in Accordance with the ACOSOG Z0011 Strategy.
Oyama Y, Kittaka N, Higuchi A, Togashi Y, Taniguchi A, Seto Y, Soma A, Park S, Okuno J, Watanabe N, Matsui S, Ishihara M, Nishio M, Honma K, Nakayama T. Oyama Y, et al. Oncology. 2024 Aug 19:1-13. doi: 10.1159/000540363. Online ahead of print. Oncology. 2024. PMID: 39159619
Plasma and serum concentrations of VEGF-A121, but not of VEGF-A165, increase post-bevacizumab administration.
Okawa M, Yamakuchi M, Bibek A, Takenouchi K, Maywar DN, Yamada S, Inoue K, Higurashi K, Nakazawa J, Kawahira M, Kodama T, Tanoue K, Oyama Y, Higashi S, Fujisaki C, Hashinokuchi H, Tabaru A, Kanda H, Tachioka S, Imoto Y, Hashiguchi T, Soga Y. Okawa M, et al. Among authors: oyama y. PLoS One. 2024 Dec 19;19(12):e0316035. doi: 10.1371/journal.pone.0316035. eCollection 2024. PLoS One. 2024. PMID: 39700124 Free PMC article.
The Vascular Endothelial Growth Factor-A121/Vascular Endothelial Growth Factor-A165 Ratio as a Predictor of the Therapeutic Response to Immune Checkpoint Inhibitors in Gastric Cancer.
Hamada Y, Tanoue K, Arigami T, Yamakuchi M, Okawa M, Matsushita D, Takenouchi K, Yamada S, Maywar DN, Nakayama C, Oyama Y, Higashi S, Fujisaki C, Hozaka Y, Kita Y, Hashiguchi T, Ohtsuka T. Hamada Y, et al. Among authors: oyama y. Cancers (Basel). 2024 Nov 26;16(23):3958. doi: 10.3390/cancers16233958. Cancers (Basel). 2024. PMID: 39682145 Free PMC article.
806 results